The National Cancer Institute is now offering a "Risk Disk"
December 1998
The National Cancer Institute is now offering a "Risk Disk"...a computer program to help women estimate their risk of developing breast cancer.
This is important now that Nolvadex (tamoxifen) is approved to reduce the incidence of breast cancer in women at high risk.
The Risk Disk asks about the woman's age...age of menarche...age at first live birth...family history of breast cancer...and personal medical history.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote